The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CVS HEALTH CORP | COM | 126650100 | 20,330 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ENDO INTL PLC | SHS | G30401106 | 34,260 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
EXPRESS SCRIPTS HLDG CO | COM | 30219G108 | 22,162 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 40,510 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
INVACARE CORP | COM | 461203101 | 16,112 | 1,023,000 | SH | SOLE | 1,023,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 76,805 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 42,350 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 5,250 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
PERRIGO CO PLC | SHS | G97822103 | 25,395 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
SELECT MED HLDGS CORP | COM | 81619Q105 | 86,400 | 4,500,000 | SH | SOLE | 4,500,000 | 0 | 0 | ||
SUPERVALU INC | COM NEW | 868536301 | 43,500 | 2,000,001 | SH | SOLE | 2,000,001 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 25,207 | 1,534,200 | SH | SOLE | 1,534,200 | 0 | 0 | ||
TIVITY HEALTH INC | COM | 88870R102 | 30,600 | 750,000 | SH | SOLE | 750,000 | 0 | 0 |